亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

異甘草素 CAS:961-29-5

 
 
單價 面議對比
詢價 暫無
發貨 四川成都市付款后3天內
品牌 鈉鈳鋰
過期 長期有效
更新 2021-11-25 12:21
 

成都鈉鈳鋰生物科技有限公司

企業會員第5年
資料未認證
保證金未繳納
詳細說明

nkl-00103
中文名稱:異甘草素
中文別名:異甘草苷元,4,2′,4′-三羥基查耳酮,4,2′,4′-三羥基查耳酮
英文名稱:Isoliquiritigenin
英文別名:2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (E)-; GU 17; Isoliquiritigen; Isoliquiritigenin;Chalcone, 2′,4,4′-trihydroxy- (6CI,7CI,8CI); (2E)-1-(2,4-
Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; 2′,4,4′-Trihydroxychalcone
CAS號:961-29-5
純度: HPLC≥98%

分子式:C15H12O4
分子量:256.25
外觀:黃色針狀結晶
溶解性:難溶于水,溶于極性較小的溶劑,如**、氯仿。
熔點: 200 °C
沸點: 504.0±42.0 °C | Condition
密度: 1.384±0.06 g/cm3 | Condition: Temp: 20 °C
pKa值: 7.50±0.35 | Condition: Most Acidic Temp: 25 °C
提取來源:甘草
藥理藥效:抗潰瘍與解痙作用,抑制單胺氧化酶和糖醛還原酶,抗腫瘤。
檢測條件:甲醇:冰醋酸:水(70:1:30);檢測波長254nm(僅供參考)
規格:10mg,20mg,50mg;可根據客戶需求包裝、定制

儲存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測定、藥理實驗、活性篩選等科研、實驗室使用;不得直接用于人體

供應商:成都鈉鈳鋰生物科技有限公司

舉報收藏 0評論 0
更多>本企業其它產品
2”-O-沒食子酰基金絲桃苷 CAS:53209-27-1 甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |